Related references
Note: Only part of the references are listed.Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7% Results From the CREDENCE Trial
Christopher P. Cannon et al.
CIRCULATION (2020)
Association of Cardiometabolic Multimorbidity With Mortality The Emerging Risk Factors Collaboration
Emanuele Di Angelantonio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
The association between depressive symptoms, cognitive function, and inflammation in major depression
Jesper Krogh et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States
Meredith C. Foster et al.
AMERICAN HEART JOURNAL (2013)
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
Linda F. Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Kidney Disease in People With Diabetes: The Expanding Epidemic
Elizabeth Selvin et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus
Makoto Sawaguchi et al.
JOURNAL OF DIABETES INVESTIGATION (2012)
Heart Disease and Stroke Statistics-2011 Update A Report From the American Heart Association
Veronique L. Roger et al.
CIRCULATION (2011)
Therapeutic management of diabetic kidney disease
Daisuke Koya et al.
JOURNAL OF DIABETES INVESTIGATION (2011)
Adipose Tissue-Specific Regulation of Angiotensinogen in Obese Humans and Mice: Impact of Nutritional Status and Adipocyte Hypertrophy
Shintaro Yasue et al.
AMERICAN JOURNAL OF HYPERTENSION (2010)
Glomerular angiotensinogen is induced in mesangial cells in diabetic rats via reactive oxygen species-ERK/JNK pathways
Naro Ohashi et al.
HYPERTENSION RESEARCH (2010)
Increased Urinary Angiotensinogen Is Precedent to Increased Urinary Albumin in Patients With Type 1 Diabetes
Toshie Saito et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2009)
Urinary Angiotensinogen as a Novel Biomarker of the Intrarenal Renin-Angiotensin System Status in Hypertensive Patients
Hiroyuki Kobori et al.
HYPERTENSION (2009)
Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases
Hiroyuki Kobori et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2008)
Novel sandwich ELISA for human angiotensinogen
Akemi Katsurada et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease
Tatsuo Yamamoto et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension
H Kobori et al.
HYPERTENSION (2003)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)